期刊论文详细信息
Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism? New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation | |
Article | |
关键词: PROTHROMBIN COMPLEX CONCENTRATE; COST-EFFECTIVENESS; DIRECT THROMBIN; DABIGATRAN; WARFARIN; NONADHERENCE; SAFETY; ADHERENCE; REVERSAL; THERAPY; | |
DOI : 10.1161/CIRCULATIONAHA.111.031153 | |
来源: SCIE |
【 授权许可】
Free